siRNA company Eleven Therapeutics seals $22M funding
Eleven Therapeutics has raised a total of $22 million in seed funding. Among the roster…
August 3, 2022 - 3 minutes
RNA technology
The coming of age story of RNAi technology
The first RNA interference (RNAi) therapy was approved in 2018, after 20 years in development.…
July 22, 2022 - 7 minutes
ICL and PlantArcBio look to use RNAi to boost crop yields
ICL, a global specialty minerals company, and ag-biotech company PlantArcBio, Ltd., have announced the development…
July 20, 2022 - 2 minutes
Study results reveal bleeding episodes are significantly reduced by hemophilia drug
People suffering from a severe blood disorder may only have to take a once-monthly drug…
July 11, 2022 - 4 minutes
Therorna funding to accelerate circRNA-based platform
Therorna Inc., a Chinese biotech company specializing in the development of circular RNA (circRNA) technology-based…
June 21, 2022 - 2 minutes
Ziphius Vaccines and University of Antwerp to work on RNA-based delivery methods
Belgian biopharma firm Ziphius Vaccines is set to collaborate with the University of Antwerp to…
June 9, 2022 - 3 minutes
Amaroq Therapeutics ‘hits early milestones’ in cancer treatment
New Zealand biotech company Amaroq Therapeutics said it is progressing towards clinical trials following a…
June 9, 2022 - 2 minutes
Patent Waiver on Covid-19 Vaccines Splits Opinions in Biotech Industry
Attempts to increase global Covid-19 vaccine coverage with a temporary patent waiver have been met…
June 15, 2021 - 5 minutes
How Are European Biotechs Tackling the Cardiovascular Disease Problem?
Cardiovascular diseases may not regularly grab the headlines, but they’re the leading cause of mortality…
March 1, 2021 - 9 minutes
A Year to Remember: The Biggest European Biotech News in 2020
The Covid-19 pandemic caused huge disruption for European biotech in 2020, but the industry pulled…
December 28, 2020 - 12 minutes
Overcoming the Limitations of CRISPR Gene Editing with RNA Editing
A once forgotten technology, RNA editing has been gaining traction as a treatment for genetic…
August 17, 2020 - 6 minutes
Silence Therapeutics to Work with AstraZeneca in RNAi Deal Worth up to €3.6B
AstraZeneca is recruiting RNAi specialist Silence Therapeutics to develop treatments for cardiovascular, renal, metabolic, and…
March 26, 2020 - 3 minutes
